Comparative Efficacy of SYSTANE® ULTRA vs Optive™ in Improving Tear Film Break-up Time
NCT ID: NCT01417013
Last Updated: 2012-02-08
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
WITHDRAWN
NA
INTERVENTIONAL
2011-07-31
2012-01-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Evaluation of the Repeated Usage of Systane Ultra Eyedrop
NCT01051804
Evaluation of Extended Tear Film Break Up Time (TFBUT) With an Ocular Emulsion
NCT01368198
Clinical Evaluation of Systane® ULTRA Compared to OPTIVE® in Ocular Surface Staining
NCT01863368
Residence Time Evaluation of Systane Ultra Lubricant Eye Drops vs. Hialid and Saline
NCT01252121
Comparison of Frequency of Use of Optive and Systane
NCT00406510
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
CROSSOVER
TREATMENT
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Systane Ultra
Systane Ultra Lubricant Eye Drops
Systane Ultra
Lubricant Eye Drops
Optive
Optive Lubricant eye drops
Optive
Lubricant eye drops
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Systane Ultra
Lubricant Eye Drops
Optive
Lubricant eye drops
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion:
* Topical ocular medication use
* Presence of Ocular conditions (blepharitis, conjunctival infections, etc)
18 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Alcon Research
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
SMA-10-07
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.